Regulating in vitro gametogenesis (IVG) for human reproduction in China: legal, ethical, medical, and Confucian sociocultural perspectives

In vitro gametogenesis (IVG) is an emerging research field that aims to derive mature, functional human gametes from pluripotent stem cells, including induced pluripotent stem cells (iPSCs) reprogrammed from somatic cells. Functional IVG-derived human gametes and human reproductive use have not yet been established. Current advances include animal models and the generation of human germ-cell progenitors. If future safety, efficacy, and societal acceptability permit clinical translation, a robust regulatory framework is needed. In China, this prospective governance question is shaped by an evolving landscape of ART regulation, demographic change, and diverse sociocultural values across various sections of Chinese society. This normative-legal analysis uses a prospective, context-sensitive interpretive approach. It critically examines the Chinese ART legal framework, related statutory provisions, and published analyses of regulatory practices alongside selected classical and contemporary Confucian scholarship on filial piety, kinship, bodily integrity, and compassionate responses to suffering. It then analyzes how these materials may illuminate—not conclusively determine—ethical and legal questions raised by possible future IVG applications, while identifying areas where plural bioethics frameworks and empirical deliberation are required. The analysis suggests that IVG may hold promise for clinically significant infertility and for reducing reliance on third-party gametes, which could resonate with some Confucian narratives of lineage continuity. It also identifies conditional concerns about consent, family relationships, genetic relatedness, and the governance of embryo creation. A Confucian-informed reading may support heightened safeguards for posthumous use without documented prospective consent; but it does not yield a singular or definitive verdict on same-sex, transgender, or intersex reproduction. The distinction between ROPA (Reception of Oocytes from Partner) and IVG concerns their different genetic, gestational, and relational configurations rather than a ranked judgment of ethical acceptability. By synthesizing current legal paradigms with cultural sensitivities, this article identifies various considerations for anticipatory IVG governance in China. These include documented prospective consent and origin tracking, proportionate limits on embryo creation, safeguards against genetic enhancement and exploitation, and institutional review that includes scientific, legal, ethical, and community perspectives. Any eventual policy should be developed gradually through public deliberation and should balance reproductive autonomy, equality, child welfare, and culturally situated concerns.